A paper published by "Nature" reported that the serum vaccinated with Pfizer-BioNTech's new coronavirus vaccine neutralized the new virus
With the emergence of new variants of the new coronavirus, it is urgent to evaluate the immune effects of existing vaccines to produce antibodies and neutralize these variants
Peiyong Shi of the University of Texas at Galveston Medical Branch and colleagues used 20 serum samples from 15 people who had received 2 doses of Pfizer-BioNTech vaccine to test the neutralizing activity of the serum against recombinant new coronaviruses and the expression of these viruses.
University of Texas Galveston Medical Division Compared with the virus strains isolated in January 2020, the serum has lower activity against the mutant strains—especially the B.
The authors concluded that this finding suggests that the vaccine may provide adequate protection against these new variants
The authors concluded that the report on the effectiveness of the vaccine against variant strains shows the importance of the vaccination schedule, which may reduce the emergence of new variants
Related paper information: https://doi.
Related paper information: https://doi.
org/10.
1038/s41586-021-03693-y
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
